Digital Health Insights

Equity

Equitable Access to Diagnostics and Medicines

Equitable distribution of diagnostics and medicines depends on aligning supply chains, financing, and clinical protocols so that every patient encounters the same standard of availability regardless of location or income.

2026-10-04 · Dr Vas editorial

The shift

Health systems are moving from centralized procurement models toward layered distribution networks that place essential diagnostics and medicines closer to primary care sites. This change recognizes that delays in testing or treatment often stem from physical distance and fragmented ordering rather than outright shortages. Operators now track both upstream manufacturing commitments and downstream last-mile delivery so that stockouts at rural clinics receive the same attention as shortages at tertiary hospitals. The shift also requires redefining equity as active redistribution rather than passive allocation, meaning facilities with historically lower utilization receive priority replenishment when new lots arrive. Clinicians contribute by documenting real-time consumption patterns that inform these adjustments. Over time the approach reduces the need for patients to travel long distances or purchase items privately, which preserves trust in public services. Sustained progress depends on shared visibility across tiers so that national planners and local teams operate from the same data streams without creating new administrative burdens.

How it works in clinic

In daily practice a clinic begins by confirming that the diagnostic menu and formulary match the most common presentations seen in that catchment area. Staff then verify inventory at the start of each session and flag any item projected to run low within two weeks. When a test or medicine is unavailable on site, the clinic follows a predefined referral pathway that includes transport support rather than leaving the patient to navigate alone. Electronic ordering links directly to regional depots so that replenishment occurs on predictable cycles instead of reactive requests. Clinicians record not only what was used but also instances where a patient left without the intended intervention, creating a feedback loop that highlights recurring gaps. Training emphasizes that equitable distribution includes explaining options clearly so patients understand why a substitute is offered or why referral is required. These steps integrate into existing workflows without lengthening visits when protocols are standardized.

Who pays

Financing for equitable distribution draws from a mix of public budgets, pooled insurance contributions, and targeted external support that covers commodities rather than overhead. National health accounts increasingly earmark lines for diagnostics and medicines separately from salaries and infrastructure so that stock levels do not compete with operational costs. At the facility level, reimbursement mechanisms reimburse the actual item dispensed rather than a bundled visit fee, which removes the incentive to ration. When external funders participate, their commitments are structured around multi-year volume guarantees that stabilize prices and encourage manufacturers to maintain dedicated production lines. Operators monitor whether payment flows reach the point of care on time, because delayed reimbursement quickly translates into reduced ordering. The overall model treats commodity financing as a core system function rather than a discretionary add-on.

Where it fails

Distribution breaks down when forecasting relies on historical averages that do not capture sudden changes in disease patterns or migration. Another frequent failure occurs when quality-assurance checks at intermediate warehouses delay release of usable stock while clinics report shortages. Regulatory differences between regions can also block rapid transfer of medicines even when surpluses exist nearby. In addition, weak last-mile transport leaves temperature-sensitive diagnostics sitting at central stores while peripheral sites improvise with less reliable alternatives. Communication gaps between procurement teams and clinical staff mean that demand signals arrive too late for corrective action. Each of these points represents a discrete process failure that can be mapped and addressed without requiring new technology platforms.

India's public health system

India's public health system illustrates both the scale of the challenge and workable responses. State-level procurement agencies now publish open dashboards showing stock positions across districts, allowing neighboring facilities to request transfers before items expire. Mission-mode programs have placed rapid diagnostic kits at sub-center level for conditions previously referred upward, shortening the interval between symptom onset and confirmed management. Medicine depots have been reorganized around geographic clusters rather than strict administrative boundaries, which improves response when one district experiences an unexpected surge. Challenges remain in ensuring uniform cold-chain performance across diverse terrains and in aligning private-sector reporting with public dashboards. The experience shows that transparency plus operational flexibility can narrow gaps even when absolute resources stay constrained.

What to do this quarter

This quarter, map every diagnostic and medicine on the essential list against current stock and projected consumption for the next eight weeks. Establish a weekly review meeting that includes both supply-chain staff and at least one clinician from each major service line. Test a simple transfer protocol between two nearby facilities so that excess at one site moves to shortage at the other within five working days. Update patient information materials to explain when referral for a test or medicine is required and what support is available. Finally, document every instance in which a patient could not complete the intended diagnostic or treatment pathway and bring those cases to the next planning session.

Three moves

  • Establish weekly stock reviews that pair supply data with clinical demand signals.
  • Create tested transfer protocols between nearby facilities to balance inventory before shortages occur.
  • Record and review every incomplete diagnostic or treatment episode to guide the next quarter's adjustments. This quarter's actions build operational habits that LetsGo.Health supports through shared tooling and peer learning.
Follow-through lives on LetsGo.Health.
Equitable Access to Diagnostics and Medicines | Dr. Vas Metupalle